Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldmit

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Circulation|April 12, 2000
Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?J Benhorin, R Taub, M Goldmit, et al.
Circulation Research|August 1, 1998
Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunitsR H An, X L Wang, B Kerem, et al.
Human Mutation|January 8, 2000
Identification of a new SCN5A mutation, D1840G, associated with the long QT syndrome. Mutations in brief no. 153. OnlineJ Benhorin, M Goldmit, J W MacCluer, et al.
Nature|November 9, 2001
Asynchronous replication and allelic exclusion in the immune systemR Mostoslavsky, N Singh, T Tenzen, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Circulation|April 12, 2000
Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?J Benhorin, R Taub, M Goldmit, et al.
Circulation Research|August 1, 1998
Novel LQT-3 mutation affects Na+ channel activity through interactions between alpha- and beta1-subunitsR H An, X L Wang, B Kerem, et al.
Human Mutation|January 8, 2000
Identification of a new SCN5A mutation, D1840G, associated with the long QT syndrome. Mutations in brief no. 153. OnlineJ Benhorin, M Goldmit, J W MacCluer, et al.
Nature|November 9, 2001
Asynchronous replication and allelic exclusion in the immune systemR Mostoslavsky, N Singh, T Tenzen, et al.
Pageof 1